Literature DB >> 26249007

[Respiratory allergies in children and adolescents: the role of component-resolved diagnosis and specific immunotherapy].

Fritz Horak1.   

Abstract

Respiratory allergies of children and adolescents are an important issue in allergology. In parallel to increasing prevalence rates also research has rapidly been developing for the last 10 years. Today we can better understand complex systems to improve our diagnostic and therapeutic accuracy. In addition to medical history, skin-prick-testing and analysis of specific IgE to allergen extracts, component resolved diagnosis has gained importance in the last years. While being increasingly helpful in the diagnosis of insect-venom and food-allergies, component-based diagnosis can also improve the management of patients with respiratory allergies. Concerning different therapeutic approaches like allergen-avoidance or symptomatic therapy, specific immunotherapy (SIT) is one of the most interesting therapy-options, as it is still the only causal therapy available. After reasonable patient-selection and the selection of the right allergen and product, SIT has a very good risk/benefit-ration and can induce long-term immuno-tolerance to specific allergens.

Entities:  

Keywords:  Allergy; Component-resolved; Diagnosis; Specific immunotherapy; Therapy

Mesh:

Substances:

Year:  2015        PMID: 26249007     DOI: 10.1007/s10354-015-0375-4

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  27 in total

Review 1.  Allergy testing in children: why, who, when and how?

Authors:  A Høst; S Andrae; S Charkin; C Diaz-Vázquez; S Dreborg; P A Eigenmann; F Friedrichs; P Grinsted; G Lack; G Meylan; P Miglioranzi; A Muraro; A Nieto; B Niggemann; C Pascual; M-G Pouech; F Rancé; E Rietschel; M Wickman
Journal:  Allergy       Date:  2003-07       Impact factor: 13.146

Review 2.  A Pitfall to Avoid When Using an Allergen Microarray: The Incidental Detection of IgE to Unexpected Allergens.

Authors:  Cristoforo Incorvaia; Marina Mauro; Erminia Ridolo; Eleni Makrì; Marcello Montagni; Giorgio Ciprandi
Journal:  J Allergy Clin Immunol Pract       Date:  2014-11-18

3.  SQ house dust mite sublingually administered immunotherapy tablet (ALK) improves allergic rhinitis in patients with house dust mite allergic asthma and rhinitis symptoms.

Authors:  Holger Mosbech; G Walter Canonica; Vibeke Backer; Frederic de Blay; Ludger Klimek; Louise Broge; Christian Ljørring
Journal:  Ann Allergy Asthma Immunol       Date:  2015-02       Impact factor: 6.347

4.  Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis.

Authors:  Karl-Christian Bergmann; Pascal Demoly; Margitta Worm; Wytske J Fokkens; Teresa Carrillo; Ana I Tabar; Hélène Nguyen; Armelle Montagut; Robert K Zeldin
Journal:  J Allergy Clin Immunol       Date:  2013-12-31       Impact factor: 10.793

5.  [Recombinant allergens. For routine use or still only science?].

Authors:  P Schmid-Grendelmeier
Journal:  Hautarzt       Date:  2010-11       Impact factor: 0.751

6.  A further evaluation of the clinical use of specific IgE antibody testing in allergic diseases.

Authors:  L Söderström; A Kober; S Ahlstedt; H de Groot; C-E Lange; R Paganelli; M H W M Roovers; J Sastre
Journal:  Allergy       Date:  2003-09       Impact factor: 13.146

7.  Discordance between aeroallergen specific serum IgE and skin testing in children younger than 4 years.

Authors:  Gabriele de Vos; Ramin Nazari; Denisa Ferastraoaru; Purvi Parikh; Rebecca Geliebter; Yikania Pichardo; Andrew Wiznia; David Rosenstreich
Journal:  Ann Allergy Asthma Immunol       Date:  2013-04-11       Impact factor: 6.347

8.  IgE antibody to Aspergillus fumigatus recombinant allergens in cystic fibrosis patients with allergic bronchopulmonary aspergillosis.

Authors:  A P Knutsen; P S Hutcheson; R G Slavin; V P Kurup
Journal:  Allergy       Date:  2004-02       Impact factor: 13.146

9.  Enhancement of hazelnut extract for IgE testing by recombinant allergen spiking.

Authors:  K Andersson; B K Ballmer-Weber; A Cistero-Bahima; J Ostling; I Lauer; S Vieths; J Lidholm
Journal:  Allergy       Date:  2007-08       Impact factor: 13.146

10.  Preventive sublingual immunotherapy in preschool children: first evidence for safety and pro-tolerogenic effects.

Authors:  Zsolt Szépfalusi; Christina Bannert; Leila Ronceray; Elisabeth Mayer; Michaela Hassler; Eva Wissmann; Eleonora Dehlink; Saskia Gruber; Alexandra Graf; Christian Lupinek; Rudolf Valenta; Thomas Eiwegger; Radvan Urbanek
Journal:  Pediatr Allergy Immunol       Date:  2014-12       Impact factor: 6.377

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.